Given the strong association between inflammation and obesity-related metabolic dysfunction, GPR81 biased agonism might be a valuable drug therapy for T2D and needs to be further investigated. The gene discussed is HCAR1; the disease is obesity due to melanocortin 4 receptor deficiency.